Neurol. praxi. 2024;25(3):192-196 | DOI: 10.36290/neu.2024.021

Refractory and super­‑refractory status epilepticus

doc. MUDr. Zdeněk Vojtěch, Ph.D., MBA, MUDr. Michaela Nová
Centrum pro epilepsie, Nemocnice Na Homolce, Praha

In this article, we give definitions of refractory and super-refractory status epilepticus (SE). Evidence-based or consensual treatment strategies are not known even for refractory SE. In super-refractory SE, the treatment options are even more ambiguous. Therefore, we also present the results of methods published in small case series or case reports. Potentially, this information may contribute to the development of in­‑house treatment protocols.

Keywords: refractory status epilepticus, super­‑refractory status epilepticus, anesthetics, epilepsy surgery, neuromodulation, electroconvulsive therapy.

Received: March 11, 2024; Revised: April 4, 2024; Accepted: April 4, 2024; Prepublished online: April 4, 2024; Published: June 20, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vojtěch Z, Nová M. Refractory and super­‑refractory status epilepticus. Neurol. praxi. 2024;25(3):192-196. doi: 10.36290/neu.2024.021.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alkhachroum A, Der­‑Nigoghossian CA, Mathews E, et al. Ketamine to treat super­‑refractory status epilepticus. Neurology. 2020;95(16):e2286-e2294. doi: 10.1212/WNL.0000000000010611. Go to original source... Go to PubMed...
    2. Alvarez V, Lee JW, Westover MB, et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology. 2016;87(16):1650-1659. doi: 10.1212/WNL.0000000000003224. Go to original source... Go to PubMed...
    3. Atkinson M, Atkinson B, Norris G, et al. Refractory status epilepticus secondary to CNS vasculitis, a role for epilepsy surgery. J Neurol Sci. 2012;315:156-159. doi: 10.1016/j.jns.2011. 11. 029. Go to original source...
    4. Bayrlee A, Ganeshalingam N, Kurczewski L, Brophy GM. Treatment of Super­‑Refractory Status Epilepticus. Curr Neurol Neurosci Rep. 2015;15(10):66. doi: 10.1007/s11910-015-0589-2. Go to original source... Go to PubMed...
    5. Bledsoe KA, Kramer AH. Propylene glycol toxicity complicating use of barbiturate coma. Neurocrit Care. 2008;9:122-4. doi: 10.1007/s12028-008-9065-z. Go to original source... Go to PubMed...
    6. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23. doi: 10.1007/s12028-012-9695-z. Go to original source... Go to PubMed...
    7. Dibué­‑Adjei M, Brigo F, Yamamoto T, et al. Vagus nerve stimulation in refractory and super­‑refractory status epilepticus - a systematic review. Brain Stimul. 2019;12(5):1101-1110. doi: 10.1016/j.brs.2019. 05. 011. Go to original source...
    8. Ernst LD, Raslan AM, Wabulya A, et al. J Neurosurg. 2023:1-9. doi: 10.3171/2023. 4. JNS23367. Epub ahead of print. Go to original source...
    9. Ferlisi M, Hocker S, Trinka E, et al. The anesthetic drug treatment of refractory and super­‑refractory status epilepticus around the world: results from a global audit. Epilepsy Behav. 2019;101(pt B):106449. doi: 10.1016/j.yebeh.2019.106449. Go to original source... Go to PubMed...
    10. Ferlisi M, Shorvon S. The outcome of therapies in refractory and super­‑refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135(Pt 8):2314-28. doi: 10.1093/brain/aws091. Go to original source... Go to PubMed...
    11. Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta­‑analysis. J Child Neurol. 1999; 14(9):602-9. doi: 10.1177/088307389901400909. Go to original source... Go to PubMed...
    12. Greiner HM, Tillema JM, Hallinan BE, et al. Corpus callosotomy for treatment of pediatric refractory status epilepticus. Seizure. 2012;21(4):307-9. doi: 10.1016/j.seizure.2012. 01. 010. Go to original source...
    13. Hawkes MA, Eliliwi M, Wijdicks EFM. The Origin of the Burst­‑Suppression Paradigm in Treatment of Status Epilepticus. Neurocrit Care. 2023 Nov 3. doi: 10.1007/s12028-023-01877-0. Epub ahead of print. Go to original source... Go to PubMed...
    14. Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new­‑onset refractory status epilepticus (NORSE), febrile infection­‑related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739-744. doi: 10.1111/epi.14016. Go to original source... Go to PubMed...
    15. Hocker S. Systemic complications of status epilepticus - An update. Epilepsy Behav. 2015;49:83-7. doi: 10.1016/j.yebeh.2015. 04. 024. Go to original source...
    16. Höfler J, Rohracher A, Kalss G, et al. (S)-Ketamine in Refractory and Super­‑Refractory Status Epilepticus: A Retrospective Study. CNS Drugs. 2016;30(9):869-76. doi: 10.1007/s40263-016-0371-2. Go to original source... Go to PubMed...
    17. Holtkamp M. Pharmacotherapy for Refractory and Super­‑Refractory Status Epilepticus in Adults. Drugs. 2018;78(3):307-326. doi: 10.1007/s40265-017-0859-1. Go to original source... Go to PubMed...
    18. Chin RF, Neville BG, Peckham C, et al. Treatment of community­‑onset, childhood convulsive status epilepticus: a prospective, population­‑based study. Lancet Neurol. 2008;7:696-703. doi: 10.1016/S1474-4422(08)70141-8. Go to original source... Go to PubMed...
    19. Katz JB, Owusu K, Nussbaum I, et al. Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist. J Clin Med. 2021;10(4):881. doi: 10.3390/jcm10040881. Go to original source... Go to PubMed...
    20. Katzell L, Beydler EM, Holbert R, et al. Electroconvulsive therapy use for refractory status epilepticus in an implantable vagus nerve stimulation patient: A case report. Front Psychiatry. 2023;14:1126956. doi: 10.3389/fpsyt.2023.1126956. Go to original source... Go to PubMed...
    21. Kellinghaus C, Rossetti AO, Trinka E, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol. 2019;85(3):421-432. doi: 10.1002/ana.25416. Go to original source... Go to PubMed...
    22. Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology. 1989;71:653-659. doi: 10.1097/00000542-198911000-00005. Go to original source... Go to PubMed...
    23. Kohrmann M, Huttner HB, Gotthardt D, et al. CSF­‑air­‑exchange for pharmacorefractory status epilepticus. J Neurol. 2006;253:1100-1101. doi: 10.1007/s00415-006-0181-4. Go to original source... Go to PubMed...
    24. Lambrecq V, Villéga F, Marchal C, et al. Refractory status epilepticus: electroconvulsive therapy as a possible therapeutic strategy. Seizure. 2012;21(9):661-4. doi: 10.1016/j.seizure.2012. 07. 010. Go to original source...
    25. Legriel S. Hypothermia as a treatment in status epilepticus: A narrative review. Epilepsy Behav. 2019;101(Pt B):106298. doi: 10.1016/j.yebeh.2019. 04. 051. Go to original source...
    26. Marchi NA, Novy J, Faouzi M, et al. Status epilepticus: impact of therapeutic coma on outcome. Critic Care Med. 2015;43(5):1003-1009. doi: 10.1097/CCM.0000000000000881. Go to original source... Go to PubMed...
    27. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205-10. doi: 10.1001/archneur.59. 2. 205. Go to original source...
    28. McGinity M, Andrade N, Karkar K, et al. Functional hemispherectomy for refractory status epilepticus in 2 adults. World Neurosurg. 2016;93:e411-486. doi: 10.1016/j.wneu.2016. 06. 086. Go to original source...
    29. McHugh P. Acute choreoathetoid reaction to propofol. Anaesthesia. 1991;46: 425. doi: 10.1111/j.1365-2044.1991.tb09583.x. Go to original source... Go to PubMed...
    30. Mulhofer WG, Layfield S, Lowenstein D, et al. Duration of therapeutic coma and outcome of refractory status epilepticus. Epilepsia. 2019;60(3):921-934. doi: 10.1111/epi.14706. Go to original source... Go to PubMed...
    31. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61(8):1254-1259. doi: 10.1001/archneur.61. 8. 1254. Go to original source...
    32. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251-256. doi: 10.1111/j.1528-1167.2009.02323.x. Go to original source... Go to PubMed...
    33. Oderiz CC, Aberastury M, Besocke AG, et al. Surgical treatment of focal symptomatic refractory status epilepticus with and without invasive EEG. Epilepsy Behav Case Rep. 2015;4:96-98. doi: 10.1016/j.ebcr.2015. 08. 005. Go to original source...
    34. Reznik ME, Berger K, Claassen J. Comparison of intravenous anesthetic agents for the treatment of refractory status epilepticus. J Clin Med. 2016;5(5):pii:E54. doi:10.3390/jcm5050054. Go to original source... Go to PubMed...
    35. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10(10):922-930. doi: 10.1016/S1474-4422(11)70187-9. Go to original source... Go to PubMed...
    36. Rossetti AO, Reichhart MD, Schaller MD, et al. Propofol treatment of refractory status epilepticus: A study of 31 episodes. Epilepsia. 2004;45(7):757-63. doi: 10.1111/j.0013-9580.2004.01904.x. Go to original source... Go to PubMed...
    37. Rubin DB, Angelini B, Shoukat M, et al. Electrographic predictors of successful weaning from anaesthetics in refractory status epilepticus. Brain. 2020;143(4):1143-1157. doi: 10.1093/brain/awaa069. Go to original source... Go to PubMed...
    38. Sabharwal V, Ramsay E, Martinez R, et al. Propofol­‑ketamine combination therapy for effective control of super­‑refractory status epilepticus. Epilepsy Behav. 2015;52(Pt A):264-6. doi: 10.1016/j.yebeh.2015. 07. 040. Go to original source...
    39. Sanchez Fernandez I, Abend NS, Agadi S, et al. Gaps and opportunities in refractory status epilepticus research in children: A multi­‑center approach by the Pediatric Status Epilepticus Research Group (pSERG). Seizure. 2014;23(2):87-97. doi: 10.1016/j.seizure.2013. 10. 004. Go to original source...
    40. San­‑Juan D, Dávila­‑Rodríguez DO, Jiménez CR, et al. Neuromodulation techniques for status epilepticus: A review. Brain Stimul. 2019;12(4):835-844. doi: 10.1016/j.brs.2019. 04. 005. Go to original source...
    41. Shorvon S, Ferlisi M. The treatment of super­‑refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802-18. doi: 10.1093/brain/awr215. Go to original source... Go to PubMed...
    42. Singh RK, Singh R, Stewart A, et al. Intravenous ganaxolone in pediatric super­‑refractory status epilepticus: a single hospital experience. Epilepsy Behav Rep. 2022;20:100567. doi: 10.1016/j.ebr.2022.100567. Go to original source... Go to PubMed...
    43. Singhi S, Murthy A, Singhi P, et al. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17:106-10. doi: 10.1177/088307380201700203. Go to original source... Go to PubMed...
    44. Singla L, Shah M, Moore­‑Hill D, et al. Electroconvulsive therapy for super refractory status epilepticus in pregnancy: case report and review of literature. Int J Neurosci. 2023;133(10):1109-1119. doi: 10.1080/00207454.2022.2050371. Go to original source... Go to PubMed...
    45. Sobstyl M, Stapińska­‑Syniec A, Rylski M. Deep brain stimulation for the treatment of refractory and super­‑refractory status epilepticus. Seizure. 2020 Oct;81:58-62. doi: 10.1016/j.seizure.2020. 07. 022. Go to original source...
    46. Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656-664. doi: 10.1212/WNL.0000000000000009. Go to original source... Go to PubMed...
    47. Trinka E, Brigo F. Neurostimulation in the treatment of refractory and super­‑refractory status epilepticus. Epilepsy Behav. 2019;101(Pt B):106551. doi: 10.1016/j.yebeh.2019.106551. Go to original source... Go to PubMed...
    48. Trinka E, Leitinger M. Management of Status Epilepticus, Refractory Status Epilepticus, and Super­‑refractory Status Epilepticus. Continuum (Minneap Minn). 2022 1;28(2):559-602. doi: 10.1212/CON.0000000000001103. Go to original source... Go to PubMed...
    49. Vasquez A, Farias­‑Moeller R, Tatum W. Pediatric refractory and super­‑refractory status epilepticus. Seizure. 2019 May;68:62-71. doi: 10.1016/j.seizure.2018. 05. 012. Go to original source...
    50. Vossler DG, Bainbridge JL, Boggs JG, et al. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020;20(5):245-264. doi: 10.1177/1535759720928269. Go to original source... Go to PubMed...
    51. Woodward MR, Doddi S, Marano C, et al. Evaluating salvage electroconvulsive therapy for the treatment of prolonged super refractory status epilepticus: A case series. Epilepsy Behav. 2023;144:109286. doi: 10.1016/j.yebeh.2023.109286. Go to original source... Go to PubMed...
    52. Yeoman P, Hutchinson A, Byrne A, et al. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med. 1989;15(4):255-259. doi: 10.1007/BF00271062. Go to original source... Go to PubMed...
    53. Zeiler FA, Zeiler KJ, Teitelbaum J, et al. VNS for refractory status epilepticus. Epilepsy Res. 2015;112:100-13. doi: 10.1016/j.eplepsyres.2015. 02. 014. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.